ALXN
Alexion Pharmaceuticals Inc
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
610 hedge funds and large institutions have $29.1B invested in Alexion Pharmaceuticals Inc in 2019 Q1 according to their latest regulatory filings, with 85 funds opening new positions, 263 increasing their positions, 191 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
610
Holders Change
+2
Holders Change %
+0.33%
% of All Funds
13.22%
Holding in Top 10
12
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+50%
% of All Funds
0.26%
New
85
Increased
263
Reduced
191
Closed
75
Calls
$196M
Puts
$221M
Net Calls
-$25.4M
Net Calls Change
-$8.13M
Top Buyers
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$395M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$371M |
| 3 |
Jennison Associates
New York
|
+$204M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$189M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$141M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$475M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
-$269M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$151M |
| 4 |
D.E. Shaw & Co
New York
|
-$93.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$75M |
